scholarly journals Advances in HIV microbicide development

2011 ◽  
Vol 3 (16) ◽  
pp. 2101-2116 ◽  
Author(s):  
Joanna S Olsen ◽  
David Easterhoff ◽  
Stephen Dewhurst
2005 ◽  
Vol 39 (2) ◽  
pp. 229-236 ◽  
Author(s):  
Diana M. Colleluori ◽  
Deborah Tien ◽  
Feirong Kang ◽  
Tara Pagliei ◽  
Ryan Kuss ◽  
...  

2016 ◽  
Vol 243 ◽  
pp. 43-53 ◽  
Author(s):  
Cassilda Cunha-Reis ◽  
Alexandra Machado ◽  
Luísa Barreiros ◽  
Francisca Araújo ◽  
Rute Nunes ◽  
...  

2018 ◽  
Vol 104 (6) ◽  
pp. 1074-1081 ◽  
Author(s):  
Yannick L. Traore ◽  
Yufei Chen ◽  
Emmanuel A. Ho

2017 ◽  
Vol 19 (3) ◽  
pp. 692-702 ◽  
Author(s):  
Jianing Meng ◽  
Vivek Agrahari ◽  
Miezan J. Ezoulin ◽  
Sudhaunshu S. Purohit ◽  
Tao Zhang ◽  
...  

2018 ◽  
Vol 8 (5) ◽  
pp. 1180-1190 ◽  
Author(s):  
Lara E. Pereira ◽  
Tyana Singletary ◽  
Amy Martin ◽  
Chuong T. Dinh ◽  
Frank Deyounks ◽  
...  

Nanomedicine ◽  
2021 ◽  
Author(s):  
Samrajya Lakshmi Yeruva ◽  
Prashant Kumar ◽  
Seetharam Deepa ◽  
Anand K Kondapi

Aim: We report here the development of tenofovir- and curcumin-loaded lactoferrin nanoparticles (TCNPs) as an HIV-microbicide. Materials & methods: TCNPs were subjected to various physicochemical characterization experiments, followed by in vitro and in vivo experiments to assess their efficacy. Results: TCNPs had a diameter of 74.31 ± 2.56 nm with a gross encapsulation of more than 61% for each drug. Nanoparticles were effective against HIV-1 replication, with an IC50 of 1.75 μM for curcumin and 2.8 μM for tenofovir. TCNPs provided drug release at the application site for up to 8–12 h, with minimal leakage into the systemic circulation. TCNPs showed spermicidal activity at ≥200 μM and induced minimal cytotoxicity and inflammation in the vaginal epithelium as revealed by histopathological and ELISA studies. Conclusion: We demonstrated that TCNPs could serve as a novel anti-HIV microbicidal agent in rats. [Formula: see text]


Sign in / Sign up

Export Citation Format

Share Document